Secondary analysis of the RESOLVE trial suggests the benefits of graded sensorimotor retraining across patient groups with chronic low back pain.
Aclarion, Inc., ('Aclarion” or the 'Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...
Explore the latest evidence from UNSW Sydney and NeuRA on non-drug, non-surgical treatments for acute and chronic low back pain (LBP). Based on a Cochrane review of over 97,000 participants, discover ...
When the University of Delaware’s Gregory Hicks started his research career two decades ago, he was one of only a few people in the United States studying chronic low back pain in people over 60 years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results